Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 183 | 228 | 671 | 463 | 180 |
| Cost of Goods | 50 | 81 | 131 | 127 | 10 |
| Gross Profit | 133 | 147 | 541 | 335 | 171 |
| Operating Expenses | 6,912 | 1,270 | 1,473 | 8,612 | 1,867 |
| Operating Income | -6,728 | -1,042 | -802 | -8,149 | -1,687 |
| Interest Expense | 249 | 225 | 102 | 140 | 79 |
| Other Income | -6 | -1 | 453 | 7,254 | -7,185 |
| Pre-tax Income | -6,984 | -1,268 | -451 | -1,035 | -8,951 |
| Net Income Continuous | -6,984 | -1,268 | -451 | -1,035 | -8,951 |
| Net Income | $-6,984 | $-1,268 | $-451 | $-1,035 | $-8,951 |
| EPS Basic Total Ops | -1.18 | -0.22 | -0.08 | -0.20 | -1.75 |
| EPS Basic Continuous Ops | -1.18 | -0.22 | -0.08 | -0.20 | -1.75 |
| EPS Diluted Total Ops | -1.18 | -0.22 | -0.08 | -0.20 | -1.75 |
| EPS Diluted Continuous Ops | -1.18 | -0.22 | -0.08 | -0.20 | -1.75 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.22 | -0.14 | N/A | N/A |
| EBITDA(a) | $-6,698 | $-1,012 | $-773 | $-8,079 | $-1,648 |